ask="0.4893"
ask_size="800"
average_daily_volume="3879320"
bid="0.4750"
bid_size="1600"
book_value="0.0720"
change="+0.0072"
change_from_200_day_moving_average="0.2754"
change_from_50_day_moving_average="0.2152"
change_from_52_week_high="-0.0805"
change_From_52_week_low="0.3525"
change_in_percent="+1.5245%"
close="0.4795"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.0430"
ebitda="-16.38M"
eps_estimate_current_year="-0.0700"
eps_estimate_next_quarter="-0.0200"
eps_estimate_next_year="-0.0800"
ex_dividend_date="N/A"
float_shares="230206000"
high="0.4975"
high_52_weeks="0.5600"
last_trade_date="3/17/2017"
last_trade_price="0.4795"
last_trade_size="226120"
last_trade_time="4:02pm"
low="0.4600"
low_52_weeks="0.1270"
market_capitalization="113.85M"
moving_average_200_day="0.2041"
moving_average_50_day="0.2643"
name="Rexahn Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="2.5000"
open="0.4800"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+134.9822%"
percent_change_from_50_day_moving_average="+81.4322%"
percent_change_from_52_week_high="-14.3750%"
percent_change_from_52_week_low="+277.5591%"
previous_close="0.4723"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.5597"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="237443000"
short_ratio="0.7200"
stock_exchange="ASE"
symbol="RNN"
volume="3606855"
weeks_range_52="0.1270 - 0.5600"
